杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/06/30 | 2,040 | 2,050 | 1,994 | 1,999 | -40 | -2% | 255,400 |
2016/06/29 | 2,070 | 2,080 | 2,030 | 2,039 | -1 | ±0% | 177,100 |
2016/06/28 | 1,960 | 2,062 | 1,950 | 2,040 | +69 | +3.5% | 281,400 |
2016/06/27 | 1,903 | 1,975 | 1,903 | 1,971 | +120 | +6.5% | 166,000 |
2016/06/24 | 2,024 | 2,028 | 1,842 | 1,851 | -158 | -7.9% | 187,700 |
2016/06/23 | 2,008 | 2,018 | 1,994 | 2,009 | +3 | +0.1% | 96,200 |
2016/06/22 | 1,998 | 2,008 | 1,977 | 2,006 | -16 | -0.8% | 124,200 |
2016/06/21 | 1,988 | 2,024 | 1,968 | 2,022 | +23 | +1.2% | 120,800 |
2016/06/20 | 2,006 | 2,021 | 1,991 | 1,999 | +33 | +1.7% | 121,600 |
2016/06/17 | 2,048 | 2,070 | 1,966 | 1,966 | -62 | -3.1% | 385,300 |
2016/06/16 | 2,075 | 2,090 | 2,014 | 2,028 | -68 | -3.2% | 190,600 |
2016/06/15 | 2,046 | 2,111 | 2,040 | 2,096 | +53 | +2.6% | 255,000 |
2016/06/14 | 2,047 | 2,065 | 2,029 | 2,043 | -1 | ±0% | 267,400 |
2016/06/13 | 2,089 | 2,089 | 2,042 | 2,044 | -80 | -3.8% | 180,700 |
2016/06/10 | 2,148 | 2,154 | 2,106 | 2,124 | +5 | +0.2% | 197,300 |
2016/06/09 | 2,117 | 2,126 | 2,105 | 2,119 | +3 | +0.1% | 130,900 |
2016/06/08 | 2,095 | 2,116 | 2,085 | 2,116 | +35 | +1.7% | 166,400 |
2016/06/07 | 2,069 | 2,087 | 2,062 | 2,081 | +23 | +1.1% | 230,900 |
2016/06/06 | 2,033 | 2,062 | 2,025 | 2,058 | -3 | -0.1% | 170,200 |
2016/06/03 | 2,055 | 2,075 | 2,054 | 2,061 | +6 | +0.3% | 165,600 |
2016/06/02 | 2,070 | 2,079 | 2,048 | 2,055 | -29 | -1.4% | 257,100 |
2016/06/01 | 2,115 | 2,126 | 2,071 | 2,084 | -61 | -2.8% | 349,100 |
2016/05/31 | 2,183 | 2,186 | 2,145 | 2,145 | -46 | -2.1% | 260,500 |
2016/05/30 | 2,197 | 2,210 | 2,178 | 2,191 | +4 | +0.2% | 117,000 |
2016/05/27 | 2,198 | 2,202 | 2,185 | 2,187 | -16 | -0.7% | 146,500 |
2016/05/26 | 2,231 | 2,245 | 2,201 | 2,203 | -1 | ±0% | 190,200 |
2016/05/25 | 2,195 | 2,249 | 2,185 | 2,204 | +58 | +2.7% | 473,000 |
2016/05/24 | 2,108 | 2,173 | 2,108 | 2,146 | +38 | +1.8% | 384,100 |
2016/05/23 | 2,091 | 2,108 | 2,072 | 2,108 | +16 | +0.8% | 143,300 |
2016/05/20 | 2,057 | 2,107 | 2,056 | 2,092 | +22 | +1.1% | 200,300 |
2016/05/19 | 2,058 | 2,079 | 2,042 | 2,070 | -4 | -0.2% | 228,100 |
2016/05/18 | 2,076 | 2,099 | 2,056 | 2,074 | -2 | -0.1% | 151,000 |
2016/05/17 | 2,043 | 2,078 | 2,033 | 2,076 | +44 | +2.2% | 217,700 |
2016/05/16 | 2,049 | 2,069 | 2,024 | 2,032 | -22 | -1.1% | 239,000 |
2016/05/13 | 2,062 | 2,079 | 2,039 | 2,054 | -19 | -0.9% | 255,600 |
2016/05/12 | 2,110 | 2,122 | 2,018 | 2,073 | -76 | -3.5% | 320,600 |
2016/05/11 | 2,164 | 2,178 | 2,123 | 2,149 | -22 | -1% | 253,900 |
2016/05/10 | 2,136 | 2,185 | 2,124 | 2,171 | +28 | +1.3% | 270,400 |
2016/05/09 | 2,161 | 2,165 | 2,134 | 2,143 | -3 | -0.1% | 113,400 |
2016/05/06 | 2,138 | 2,166 | 2,125 | 2,146 | +2 | +0.1% | 180,400 |
2016/05/02 | 2,091 | 2,144 | 2,091 | 2,144 | -40 | -1.8% | 183,100 |
2016/04/28 | 2,259 | 2,275 | 2,182 | 2,184 | -78 | -3.4% | 283,000 |
2016/04/27 | 2,316 | 2,325 | 2,249 | 2,262 | -52 | -2.2% | 229,900 |
2016/04/26 | 2,296 | 2,329 | 2,287 | 2,314 | -2 | -0.1% | 127,800 |
2016/04/25 | 2,359 | 2,359 | 2,302 | 2,316 | -42 | -1.8% | 247,900 |
2016/04/22 | 2,326 | 2,361 | 2,312 | 2,358 | +19 | +0.8% | 158,900 |
2016/04/21 | 2,332 | 2,349 | 2,312 | 2,339 | +42 | +1.8% | 133,200 |
2016/04/20 | 2,305 | 2,344 | 2,285 | 2,297 | +4 | +0.2% | 167,600 |
2016/04/19 | 2,296 | 2,346 | 2,268 | 2,293 | +54 | +2.4% | 196,300 |
2016/04/18 | 2,222 | 2,261 | 2,222 | 2,239 | -54 | -2.4% | 108,800 |
2151~
2200
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 147,600円 | +3.2% | +4.5% | 3.52% | 16.96倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ジーエヌアイ | 222,700円 | +21.7% | +999.9% | 0.00% | 9.27倍 | 3.07倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 306,500円 | +3.0% | +27.5% | 2.61% | 19.40倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 225,300円 | +0.4% | -8.4% | 2.35% | 28.92倍 | 1.64倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 85,000円 | +22.8% | - | 0.00% | 69.44倍 | 1.12倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム